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Adenocarcinoma of the gastric cardia (C-Ca) is possibly a specific subtype of gastric carcinoma. The purpose of this study was to
clarify the differences in the clinicopathological characteristics between C-Ca and adenocarcinoma of the distal stomach (D-Ca), and
also the differences in the expressions of gastric and intestinal phenotypic markers and genetic alterations between the two. The
clinicopathological findings in 72 cases with C-Ca were examined and compared with those in 170 cases with D-Ca. The phenotypic
marker expressions examined were those of human gastric mucin (HGM), MUC6, MUC2 and CD10. Furthermore, the presence of
mutations in the APC, K-ras and p53 genes and the microsatellite instability status of the tumour were also determined. C-Ca was
associated with a significantly higher incidence of differentiated-type tumours and lymphatic vessel invasion (LVI) as compared with
D-Ca (72.2 vs 48.2%, P¼0.0006 and 72.2 vs 55.3%, P¼0.0232, respectively). Oesophageal invasion by the tumour beyond the
oesophago-gastric junction (OGJ) was found in 56.9% of cases with C-Ca; LVI in the area of oesophageal invasion was demonstrated
in 61% of these cases. Also, LVI was found more frequently in cases of C-Ca with oesophageal invasion than in those without
oesophageal invasion (82.9 vs 58.1%, P¼0.0197). The incidence of undifferentiated-type tumours was significantly higher in cases
with advanced-stage C-Ca than in those with early-stage C-Ca (5 vs 36.5%, P¼0.0076). A significantly greater frequency of HGM
expression in early-stage C-Ca and significantly lower frequency of MUC2 expression in advanced-stage C-Ca was observed as
compared with the corresponding values in cases of D-Ca (78.9 vs 52.2%, P¼0.0402 and 51.5 vs 84.6%, P¼0.0247, respectively).
Mutation of the APC gene was found in only one of all cases of C-Ca, and the frequency of mutation of the APC gene was
significantly lower in cases of C-Ca than in those of D-Ca (2.4 vs 20.0%, P¼0.0108). The observations in this study suggest that C-Ca
is a more aggressive tumour than D-Ca. The differences in biological behavior between C-Ca and D-Ca may result from the different
histological findings in the wall of the OGJ and the different genetic pathways involved in the carcinogenesis.
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Gastric carcinomas can be subdivided into distal gastric carcinomas
and proximal cardiac carcinomas. Although gastric adenocarcino-
ma remains the major cause of cancer death worldwide, its
incidence and mortality appear to have decreased in recent decades
(Parkin et al, 1988; Boring et al, 1991). A striking feature of this
decline is the rapid and comparable increase in the incidence of
adenocarcinoma of the oesophago-gastric junction (OGJ), for
example, adenocarcinomas of the gastric cardia (C-Ca) and of the
distal oesophagus (O-Ca)(Blot et al, 1991; Pera et al, 1993).
It appears that C-Ca may be a specific subtype of gastric
carcinoma. It is associated with reflux symptoms, predominance in
white males and a greater frequency of differentiated-type tumours
as compared with adenocarcinoma of the distal stomach (D-Ca). It
has also been described to show a greater tendency towards deeper
wall penetration, lymph node metastasis, and a poor prognosis
(Kalish et al, 1984; Wang et al, 1986; MacDonald and MacDonald,
1987; Hamilton et al, 1988; Clark et al, 1994; Ohno et al,1 9 9 5 ;S i e w e r t
and Stein, 1996; Kajiyama et al, 1997; Pinheiro et al, 1999; Tajima
et al, 2001a). We have previously reported that early-stage of C-Ca is
associated with higher frequency of gastric phenotypic marker
expression and lower frequency of intestinal metaplasia of the
surrounding mucosa as compared with early-stage of D-Ca (Tajima
et al, 2001a). Recent investigations have also shown that genetic
aberrations in the C-Ca gene are probably more closely associated
with O-Ca than with D-Ca (El-Rifai et al, 2001; Stocks et al, 2001).
These differences in characteristics between C-Ca and D-Ca suggest
that C-Ca might represent a distinct subtype of gastric carcinoma.
However, the differences in clinicopathological characteristics,
gastric and intestinal phenotypic marker expressions, and genetic
alterations between C-Ca and D-Ca have not yet been well clarified.
In this study, we examined the clinicopathological character-
istics, gastric and intestinal phenotypic marker expressions and
genetic alterations, such as mutations of the APC, K-ras and p53
genes and the microsatellite instability (MSI) status in 72 cases of
C-Ca in comparison with those in 170 cases of D-Ca. The purpose
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sof this study was to clarify the differences in the clinicopatholo-
gical characteristics between C-Ca and D-Ca in the Japanese
population, and also the differences with regard to gastric and
intestinal phenotypic marker expressions and genetic alterations
between the two.
METHODS
Patients
Our patient series consisted of 72 patients who had undergone
oesophago-gastrectomy for C-Ca between 1998 and 2005 at Showa
University Hospital. We also examined 170 patients who had
undergone gastrectomy for D-Ca between 2001 and 2005 at the
same hospital. For the analysis of the genetic alterations in the
tumours, written informed consent was obtained from all of the
patients before their participation in this study.
Histological review
In this study, the macroscopic OGJ was identified as the junction
between the end of the tubular oesophagus and the proximal heads
of the gastric folds, and tumours with the tumour centre within 2cm
of the macroscopic OGJ were defined as C-Ca (Japanese Gastric
Cancer Association, 1998). Resected specimens were fixed in 10%
buffered formalin, and the entire length of each lesion was cut into
5-mm-wide sections. All the specimens were embedded in paraffin
and processed to obtain 4-mm-thick sections, which were then
stained with hematoxylin and eosin (H&E). The histological OGJ
and the histological distribution of the tumour were reconstructed
on the macroscopic copy of the resected specimens so that the
origin of the tumour could be confirmed as being at the gastric
cardia and the length of the tumour extension into the oesophagus
could be identified. The histological OGJ was identified on the basis
of the following histopathological landmarks: the most distal site of
detection of oesophageal glands in the submucosal layer, the most
distal site of detection of squamous epithelium, and the detection of
a double muscularis mucosa in the longitudinally oriented sections
(Takubo et al, 1991; Tajima et al, 1999). When the intramucosal
lesion and more than half of the tumour were located in the gastric
cardia, the tumour was regarded as a C-Ca.
Analysis of expressions of phenotypic markers
The following mouse monoclonal antibodies were used: 45M1
(Novocastra Laboratories Ltd, UK), diluted 1:50, to detect HGM;
CLH5 (Novocastra Laboratories Ltd), diluted 1:50, to detect MUC6
glycoprotein; Ccp58 (Novocastra Laboratories Ltd), diluted 1:100,
to detect MUC2 glycoprotein; 56C6 (Novocastra Laboratories Ltd),
diluted 1:40, to detect CD10 glycoprotein expression. 45M1 and
CLH5 were examined as the gastric-phenotype markers, and Ccp58
and 56C6 were examined as the intestinal-phenotype markers.
HGM is synonymous with MUC5AC and the antibody is known to
react with surface foveolar cells in the stomach (Bara et al, 1998;
Nollet et al, 2002). MUC6 glycoprotein is expressed in the mucous
cells of the neck zone of the oxyntic mucosa and in the antral
glands (De Bolos et al, 1995; Reis et al, 1999). MUC2 glycoprotein
is an intestinal apomucin, which is also known to be expressed in
the supranuclear region of the goblet cells in regions of the
stomach showing intestinal metaplasia (Kim and Gum, 1995; Reis
et al, 1999). CD10 glycoprotein is known to be expressed on the
brush border of the intestinal epithelial cells (Ronco et al, 1984;
Trejdosiewicz et al, 1985). The avidin–biotinyl–peroxidase
complex immunohistochemical method was used for all the
immunohistochemical studies, in accordance with a previously
described protocol (Hsu et al, 1981).
With regard to the evaluations of HGM, MUC6, MUC2 and CD10
staining, distinct staining in more than 5% of the tumour cells was
recorded as positive immunoreactivity for the relevant marker
(Figure 1). The tumours were classified into four different
phenotypes on the basis of the results of the immunohistochemical
analysis: tumours with gastric phenotypic cells accounting for
more than 5% of the cell population were classified as gastric- (G-)
phenotype tumours; those with intestinal phenotypic cells
accounting for more than 5% of the cell population were classified
as intestinal- (I-) phenotype tumours; those with both gastric and
intestinal phenotypic cells accounting for more than 5% of the cell
population were classified as gastric and intestinal mixed- (GI-)
phenotype tumours; and those with both gastric and intestinal
phenotypic cells accounting for less than 5% of the cell population
were classified as carcinomas of unclassified- (UC-) phenotype
(Tajima et al, 2004).
DNA extraction
Microdissection of 10mm-thick formalin-fixed, paraffin-embedded
serial sections was performed on H&E stained sections for both
tumour tissue and normal mucosa. Tissues were precisely
microdissected under microscopic visualization using a PixCell
laser capture microdissection system (Arcus Engineering, Moun-
tain View, CA, USA) to avoid DNA contamination with that of
inflammatory or stromal cell nuclei. Genomic DNA was extracted
from the microdissected tissue as described previously (Konishi
et al, 2004).
Gene mutation analysis
Mutations of the APC gene in exon 15, codons 1260–1596 and the
K-ras gene in codons 12–13 were detected by fluorescence-based
PCR-single-strand conformation polymorphism (PCR-SSCP)
analysis using primers described previously (Hiyama et al, 2002;
Lee et al, 2002; Yamazaki et al, 2006). After amplification, the PCR
products from each sample were examined for mutations of the
APC or K-ras gene, by fluorescence-based single-strand conforma-
tion polymorphism analysis using the ALFexpress DNA sequencer
(Amersham Biosciences, NJ, USA) with a cooling bath. Peak
patterns were analysed using the ALFwin Fragment Analyzer
Programme (Amersham Biosciences), and shifted peaks were
defined as mutations in the respective DNA fragment. The
nucleotide sequences of the DNA fragments with shifted peaks
were determined as described previously. All mutations were
reconfirmed by independent PCR reactions and sequencing.
Mutations of the p53 gene in the exon 5–8 region were detected
by fluorescence-based PCR-SSCP analysis using capillary electro-
phoresis (Makino et al, 2000; Yamazaki et al, 2006). The nucleotide
sequences of the primers have been described previously.
Mutations were detected by electrophoresis using a 3100 Genetic
Analyzer (Applied Biosystems, CA, USA). The peak pattern was
analysed using the QUISCA software (Konishi et al, 2004; Yamazaki
et al, 2006). The nucleotide sequences of the DNA fragments with
shifted peaks were determined using the Genetic Analyzer 310 with
a BigDye Terminator (Applied Biosystems). All mutations were
reconfirmed by independent PCR and sequencing (Figure 2).
MSI analysis
MSI was detected using five microsatellite markers: BAT-25,
BAT-26, D2S123, D5S346, and D17S250. The primers and PCR
conditions have been described elsewhere (Konishi et al, 2004;
Yamazaki et al, 2006). The samples were subjected to capillary
electrophoresis on an ABI 3100 Genetic Analyzer using the
Genescan Analysis software (Applied Biosystems). An allelic shift
MSI in a microsatellite marker was identified by the presence of at
least one additional band in the tumour DNA that was not present
in the control DNA. A specimen was considered to be MSI-positive
when allelic shift was observed for at least one marker. A tumour
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ssample was considered to contain high-frequency MSI (MSI-H) if
two or more of the five informative markers exhibited instability,
and to contain low-frequency MSI (MSI-L) when only one marker
was unstable. All PCR were repeated on the same sample and only
consistent changes in duplicate reactions were scored as abnorm-
alities (Figure 3).
Statistical analysis
The data were analysed by Student’s t-test or Mann–Whitney’s
U-test and the w
2 test or Fisher’s exact test. The level of significance
was set at Po0.05.
RESULTS
Clinicopathological characteristics of adenocarcinoma of
the gastric cardia and distal stomach
Comparisons of the clinicopathological characteristics between
C-Ca and D-Ca are shown in Table 1. C-Ca was associated with
more advanced age of the patients and a higher frequency of
elevated-type tumours, differentiated-type tumours and lymphatic
vessel invasion (LVI) as compared with D-Ca (P¼0.0406, 0.0067,
0.0010, and 0.0336, respectively).
Oesophageal invasion and lymphatic vessel invasion in the
area of oesophageal invasion in adenocarcinoma of the
gastric cardia
Oesophageal invasion by the tumour beyond the histological OGJ
was found in 41 of the 72 (56.9%) cases with C-Ca, including five of
the 20 (25.0%) with early-stage tumours (tumour invasion limited
to the submucosa) and 36 of the 52 (69.2%) with advanced-stage
tumours (tumour invasion extending deeper than the muscularis
propria). The mean length of oesophageal invasion was 12.8mm
(3.6mm in the early-stage tumours and 14.1 in the advanced-stage
tumours). Among the 41 cases of C-Ca showing oesophageal
invasion, LVI in the area of oesophageal invasion was found in 25
(61.0%), including one of the five (20.0%) with early-stage tumours
and 24 of the 36 (66.7%) with advanced-stage tumours. In the
majority of cases, the LVI in the area of oesophageal invasion was
AB
D C
Figure 1 Immunohistochemical analysis of the expressions of phenotypic markers in gastric carcinoma. (A) Human gastric mucin (HGM) expressed in the
cancer cell cytoplasm (45M1, original magnification  200). (B) MUC6 glycoprotein expressed in the cancer cell cytoplasm (CLH5, original magnification
 100). (C) MUC2 glycoprotein expressed in the cancer cell cytoplasm (Ccp58, original magnification  100). (D) CD10 glycoprotein expressed on the
luminal surfaces of cancerous glands (56C6, original magnification  200).
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Figure 2 Mutation analysis of the APC gene in gastric carcinoma. (A) PCR-single-strand conformation polymorphism (PCR-SSCP) analysis shows a shifted
peak (arrowhead) as compared with that for the control normal DNA (T: tumour DNA, N: normal DNA). (B) DNA sequence analysis reveals frameshift
mutation (CCTA, 4bp deletion) at codon 1542 of the APC gene.
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sdemonstrated in the lamina muscularis mucosa and/or submucosa
beneath the non-neoplastic suqamous epithelium of the oesopha-
gus (Table 2A) (Figure 4).
Table 2B shows the incidence of LVI in the cases of C-Ca
according to the presence of oesophageal invasion. LVI was found
in 18 of the 31 (58.1%) cases of C-Ca without oesophageal invasion
(five of the 15 (33.3%) with early-stage tumours and 12 of the 16
(75.0%) with advanced-stage tumours) and 34 of 41 (82.9%) cases
of C-Ca with oesophageal invasion [two of five (40.0%) with early-
stage tumours and 32 of the 36 (88.9%) with advanced-stage
tumours]. The incidence of LVI was significantly higher in the C-
Ca cases showing oesophageal invasion than in those without
oesophageal invasion (P¼0.0196).
Histologic-type of adenocarcinoma of the gastric cardia
and distal stomach according to the tumour stage
The histologic type of C-Ca and D-Ca according to the tumour
stage is shown in Table 3. Among the 72 cases of C-Ca,
differentiated and undifferentiated-type tumours were found in
19 (95.0%) and one (5.0%) of 20 cases with early-stage tumours,
respectively, and in 33 (63.5%) and 19 (36.5%) of 52 cases with
advanced-stage tumours, respectively. Among the 170 cases of D-
Ca, differentiated and undifferentiated-type tumours were found
in 40 (58.0%) and 29 (42.0%) of the 69 cases with early-stage
tumours, respectively, and 42 (41.6%) and 59 (58.4%) of the 101
cases with advanced-stage tumours, respectively. The prevalence of
differentiated-type tumours in the cases of C-Ca was significantly
higher than that in the case of D-Ca, among both early- and
advanced-stage tumours (P¼0.0011 and P¼0.0227, respectively).
Among the 72 cases of C-Ca, the prevalence of undifferentiated-
type tumours was significantly higher in the cases with advanced-
stage tumours than in those with early-stage tumours (P¼0.0076).
On the other hand, among the cases of D-Ca, although there was a
tendency towards a higher prevalence of undifferentiated-type
tumours in cases with advanced-stage tumours as compared with
that in cases with early-stage tumours, the difference was not
significant (P¼0.103).
Phenotypic marker expressions in differentiated-type
adenocarcinoma of the gastric cardia and distal stomach
Comparisons of the phenotypic marker expressions in differen-
tiated-type C-Ca and D-Ca are shown in Table 4. Expressions of
HGM, MUC6, MUC2 and CD10 were demonstrated in 33 (63.5%),
35 (67.3%), 31 (59.6%) and 19 (36.5%) cases of the 52 cases of C-Ca
with differentiated-type tumours, respectively, and 46 (56.1%), 48
(58.5%), 64 (78.0%) and 23 (28.0%) cases of the 82 cases of D-Ca
with differentiated-type tumours, respectively. The incidence of
HGM expression was significantly higher in cases with early-stage
C-Ca than in those with early-stage D-Ca (78.9 vs 52.2%,
P¼0.0402). The incidence of MUC2 expression was significantly
lower in cases with advanced-stage C-Ca than in those with
advanced-stage D-Ca (51.5 vs 84.6%, P¼0.0493), and also in all
cases with differentiated-type C-Ca than in those with differen-
tiated-type D-Ca (59.6 vs 78.0%, P¼0.0363).
Genetic alterations in differentiated-type adenocarcinoma
of the gastric cardia and distal stomach
Comparisons of the genetic alterations in differentiated-type C-Ca
and D-Ca are shown in Table 5. Mutations of the APC, K-ras and
p53 genes were detected in one (2.4%), three (7.3%) and 15
(36.6%) of the 52 cases of C-Ca with differentiated-type tumours,
respectively, and 16 (20.0%), five (6.3%) and 20 (25.0%) of the 82
cases of D-Ca with differentiated-type tumours, respectively. The
frequency of the APC gene mutation was significantly lower in
cases with early-stage C-Ca than in those with early-stage D-Ca (0
vs 20.3%, P¼0.0341) and also in all cases with differentiated-type
C-Ca than in those with differentiated-type D-Ca (2.4 vs 20.0%,
Table 1 Clinicopathological characteristics of adenocarcinoma of the
gastric cardia and distal stomach
Variables C-Ca (n¼72) D-Ca (n¼170) P-value
Age (years) 68.4710.1 65.0710.1 0.0406
Gender
Male 55 (76.4%) 111 (65.3%) NS
Female 17 (23.6%) 59 (34.7%)
Unknown 0 0
Macroscopic type
Elevated 13 (18.1%) 10 (6.3%) 0.0067
Ulcerative 43 (59.7%) 96 (60.0%)
Flat 16 (22.2%) 54 (33.8%)
Unknown 0 10
Tumour size (mm) 50.1726.2 57.0739.8 NS
Histologic-type
Differentiated 52 (72.2%) 82 (48.2%) 0.0010
Undifferentiated 20 (27.8%) 88 (51.8%)
Unknown 0 0
Depth of invasion
M,SM 20 (27.8%) 69 (40.6%) NS
MP,SS,SE,SI 52 (72.2%) 101 (59.4%)
Unknown 0 0
Lymphatic vessel invasion
Negative 20 (27.8%) 72 (43.4%) 0.0336
Positive 52 (72.2%) 94 (56.6%)
Unknown 0 4
Blood vessel invasion
Negative 38 (52.8%) 108 (65.1%) NS
Positive 34 (47.2%) 58 (34.9%)
Unknown 0 4
Lymph node metastasis
Negative 30 (41.7%) 93 (55.0%) NS
Positive 42 (58.3%) 76 (45.0%)
Unknown 0 1
C-Ca, adenocarcinoma of the gastric cardia; D-Ca, adenocarcinoma of the distal
stomach; M, mucosa; SM, submucosa; MP, muscularis propria; SS, subserosa; SE,
serosa exposed; SI, serosa infiltrating adjacent tissue; NS., not significant.
T
N
Figure 3 Microsatellite instability analysis in gastric carcinoma. MSI
analysis using the BAT-25 marker shows a different allelic shift peak
(arrowhead) as compared with that of the control normal DNA (T: tumour
DNA, N: normal DNA).
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sP¼0.0108). There was no significant difference in the frequency of
mutations of the K-ras and p53 genes among the patient groups.
MSI-L tumours and MSI-H tumours were found in four (9.4%) and
one (2.4%) of the 52 cases of C-Ca with differentiated-type
tumours, and eight (10.0%) and five (6.3%) of the 82 cases of
D-Ca with differentiated-type tumours. There was no significant
difference in the MSI status between cases with differentiated-type
C-Ca and differentiated-type D-Ca tumours.
DISCUSSION
C-Ca and D-Ca are characterized by important differences in both
aetiological and clinical backgrounds. Several previous reports
have described a greater tendency of C-Ca than D-Ca towards
deeper wall penetration, lymph node metastasis and poor
prognosis, indicating that C-Ca may be a more aggressive tumour
than D-Ca (Kalish et al, 1984; Wang et al, 1986; MacDonald and
MacDonald, 1987; Hamilton et al, 1988; Clark et al, 1994; Ohno
et al, 1995; Siewert and Stein, 1996; Kajiyama et al, 1997; Pinheiro
et al, 1999; Tajima et al, 2001a). In this study, C-Ca was associated
with a significantly higher prevalence of LVI than D-Ca. LVI has
been regarded as an indicator of tumour aggressiveness in several
cancers. The prognostic value of LVI has been demonstrated for
diverse tumour entities like gastric carcinoma, adenocarcinoma of
the OGJ and squamous cell carcinoma of the oesophagus (Gabbert
et al, 1992; Brucher et al, 2001; von Rahden et al, 2005). Therefore,
our findings in this study may show the greater aggressiveness of
C-Ca than that of D-Ca. Furthermore, in this study, we found
specific characteristics of C-Ca in terms of the histological features,
phenotypic marker expressions and genetic alterations that might
be related to the differences in the biological behavior between
C-Ca and D-Ca.
Adenocarcinoma of the OGJ frequently extends across the OGJ
to involve both the oesophagus and the stomach. In this study,
oesophageal invasion by the tumour beyond the OGJ was
frequently (56.9% of the cases) found in cases of C-Ca. In addition,
LVI in the lamina muscularis mucosa or submucosa in the area of
oesophageal invasion was demonstrated in 61% of C-Ca cases with
oesophageal invasion. LVI was more frequently found in C-Ca
cases showing oesophageal invasion than in those without
oesophageal invasion. Histologically, the oesophageal wall shows
significant differences in the structure, especially of the lymphatic
and vascular vessels, from the gastric wall. The oesophageal
mucosal layer shows an abundance of lymphatic and vascular
vessels within a well-developed loose connective tissue layer; the
stomach mucosa lacks this characteristic (Goseki et al, 1992).
Therefore, these specific histological findings in the wall of the OGJ
would seem to be important for tumour development in cases of
C-Ca through the oesophageal wall and lymphatic vessels. C-Ca
may easily invade the oesophagus and lymphatic vessels in the
mucosa and submucosa of the oesophagus. The high incidence of
the oesophageal invasion and LVI in the area of oesophageal
invasion in cases of C-Ca might be one of the reasons for the
difference in the incidence of LVI between cases of C-Ca and D-Ca.
C-Ca has been reported to be associated with a higher incidence
of differentiated-type tumours as compared with D-Ca (Siewert
and Stein, 1996; Tajima et al, 2001a). This study revealed that 95%
of cases with early-stage C-Ca had differentiated-type tumours.
The incidence of differentiated-type tumours was significantly
higher in the C-Ca cases than in the D-Ca cases, irrespective of the
tumour stage. However, the incidence of undifferentiated-type
Table 2A Oesophageal invasion and lymphatic vessel invasion in the area of oesophageal invasion in adenocarcinoma of the gastric cardia
Tumour
stage n
Number of cases with
oesophageal invasion invasion
Mean length of
oesophageal invasion (mm)
Number of cases with lymphatic
invasion in the area of oesophageal
Early 20 5 (25.0%) 3.6 (2–5) 1 (20.0%)
Advanced 52 36 (69.2%) 14.1 (4–75) 24 (66.7%)
Total 72 41 (56.9%) 12.8 (2–75) 25 (61.0%)
Figure 4 Oesophageal invasion and lymphatic vessel invasion in the area
of oesophageal invasion in adenocarcinoma of the gastric cardia. Cancerous
cells invading the oesophageal wall under the squamous epithelium and
lymphatic vessel invasion are apparent (arrowhead).
Table 2B The incidence of lymphatic vessel invasion in adenocarcinoma
of the gastric cardia according to the presence of the oesophageal invasion
Lymphatic vessel invasion
Tumour
stage
C-Ca without
oesophageal invasion
C-Ca with
oesophageal invasion
Early n¼15 5 (33.3%) n¼5 2 (40.0%)
Advanced n¼16 12 (75.0%) n¼36 32 (88.9%)
Total
a n¼31 17 (58.1%) n¼41 34 (82.9%)
C-Ca, adenocarcinoma of the gastric cardia;
aP¼0.0196.
Table 3 Histologic type of adenocarcinoma of the gastric cardia and
distal stomach according to the tumour stage
Tumour stage
C-Ca
(n¼72)
D-Ca
(n¼170)
P-value
(AGC vs ADS)
Early
Differentiated 19 (95.0%) 39 (58.0%) 0.0011
Undifferentiated 1 (5.0%) 30 (42.0%)
Advanced
Differentiated 33 (63.5%) 43 (41.6%) 0.0227
Undifferentiated 19 (36.5%) 58 (58.4%)
P-value (early vs advanced) 0.0076 NS
C-Ca, adenocarcinoma of the gastric cardia; D-Ca, adenocarcinoma of the distal
stomach.
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stumours in cases with advanced-stage C-Ca was significantly
higher than that in cases with early-stage C-Ca. On the other hand,
such findings were not noted in D-Ca. Therefore, it would seem
that in the majority of cases, C-Ca arise as a differentiated-type
tumour in the incipient phase of carcinogenesis. In addition, our
findings in this study suggest that C-Ca is more likely to transform
from differentiated- into undifferentiated-type carcinomas with
tumour progression.
Phenotypic marker expressions and genetic alterations during
carcinogenesis have been reported to differ markedly according to
the histologic-type of tumours (Tajima et al, 2001b). In this study,
we compared the phenotypic marker expressions and genetic
alterations between differentiated-type C-Ca and differentiated-
type D-Ca, because the majority of our C-Ca cases, especially those
with early-stage tumours, had differentiated-type tumours. Pheno-
typic marker expressions had initially been investigated to
examine the tissue of origin in several cancers, including gastric
carcinoma. Among gastric carcinomas, G-phenotype tumours have
been reported to account for 27.7% of all differentiated-type
tumours, often referred to as intestinal-type tumours by Lauren,
Table 4 Phenotypic marker expressions in differentiated-type adenocarcinoma of the gastric cardia and distal stomach
C-Ca D-Ca
Phenotypic markers Early (n¼19) Advanced (n¼33) Total (n¼52) Early (n¼69) Advanced (n¼13) Total (n¼82)
Human gastric mucin expression
a
Negative 4 (21.1%) 15 (45.5%) 19 (36.5%) 33 (47.8%) 7 (53.8%) 40 (48.8%)
Positive 15 (78.9%) 18 (54.5%) 33 (63.5%) 36 (52.2%) 6 (46.2%) 42 (51.2%)
MUC6 expression
Negative 6 (31.6%) 11 (33.3%) 17 (32.7%) 26 (37.7%) 8 (61.5%) 34 (41.5%)
Positive 13 (68.4%) 22 (66.7%) 35 (67.3%) 43 (62.3%) 5 (38.5%) 48 (58.5%)
MUC2 expression
b
Negative 5 (26.3%) 16 (48.5%) 21 (40.4%) 16 (23.2%) 2 (15.4%) 18 (22.0%)
Positive 14 (73.7%) 17 (51.5%) 31 (59.6%) 53 (76.8%) 11 (84.6%) 64 (78.0%)
CD10 expression
Negative 16 (84.2%) 17 (51.5%) 33 (63.5%) 49 (71.0%) 10 (76.9%) 59 (72.0%)
Positive 3 (15.8%) 16 (48.5%) 19 (36.5%) 20 (29.0%) 3 (23.1%) 23 (28.0%)
Phenotypic marker expression pattern
G-phenotype 4 (21.1%) 7 (21.2%) 11 (21.2%) 12 (17.3%) 2 (15.4%) 14 (17.1%)
GI-phenotype 14 (73.7%) 20 (60.6%) 34 (65.4%) 41 (59.4%) 6 (46.2%) 47 (57.3%)
I-phenotype 1 (5.3%) 5 (15.2%) 6 (11.5%) 16 (23.2%) 5 (38.5%) 21 (25.6%)
UC-phenotype 0 (0) 1 (3.0%) 1 (1.9%) 0 (0) 0 (0) 0 (0)
C-Ca, adenocarcinoma of the gastric cardia; D-Ca, adenocarcinoma of the distal stomach.
aP¼0.0402 (early adenocarcinoma of the gastric cardia vs early adenocarcinoma of the
distal stomach).
bP¼0.0493 (advanced adenocarcinoma of the gastric cardia vs advanced adenocarcinoma of the distal stomach) and P¼0.0363 (total adenocarcinoma of the
gastric cardia vs total adenocarcinoma of the distal stomach).
Table 5 Genetic alterations in differentiated-type adenocarcinoma of the gastric cardia and distal stomach
C-Ca D-Ca
Genetic alterations Early (n¼19) Advanced (n¼33) Total (n¼52) Early (n¼69) Advanced (n¼13) Total (n¼82)
APC gene mutation
a
Negative 19 (100%) 21 (95.5%) 40 (97.6%) 55 (79.7%) 9 (81.8%) 64 (80.0%)
Positive 0 (0) 1 (4.5%) 1 (2.4%) 14 (20.3%) 2 (18.2%) 16 (20.0%)
Not examined 0 11 11 0 2 2
K-ras gene mutation
Negative 18 (94.7%) 20 (90.9%) 38 (92.7%) 65 (94.2%) 10 (90.9%) 75 (93.8%)
Positive 1 (5.3%) 2 (9.1%) 3 (7.3%) 4 (5.8%) 1 (9.1%) 5 (6.3%)
Not examined 0 11 11 0 2 2
P53 gene mutation
Negative 16 (84.2%) 10 (45.5%) 26 (63.4%) 53 (76.8%) 7 (63.6%) 60 (75.0%)
Positive 3 (15.8%) 12 (54.5%) 15 (36.6%) 16 (23.2%) 4 (36.4%) 20 (25.0%)
Not examined 0 11 11 0 2 2
MSI status
MSS 17 (89.5%) 19 (86.4%) 36 (87.8%) 58 (84.1%) 9 (81.8%) 67 (83.8%)
MSI-L 2 (10.5%) 2 (9.1%) 4 (9.8%) 7 (10.1%) 1 (9.1%) 8 (10.0%)
MSI-H 0 (0) 1 (4.5%) 1 (2.4%) 4 (5.8%) 1 (9.1%) 5 (6.3%)
Not examined 0 11 11 0 2 2
C-Ca, adenocarcinoma of the gastric cardia; D-Ca, adenocarcinoma of the distal stomach.
aP¼0.0341 (early adenocarcinoma of the gastric cardia vs early adenocarcinoma of the
distal stomach) and P¼0.0108 (total adenocarcinoma of the gastric cardia vs total adenocarcinoma of the distal stomach).
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swhereas I-phenotype tumours have been reported to account for
10.1% of all undifferentiated-type tumours (Tatematsu et al, 1990;
Egashira et al, 1999; Tajima et al, 2001a,b, 2004; Yamazaki et al,
2006). These previous data suggest that gastric carcinomas may
arise from various types of gastric mucosa, although differentiated-
type tumours have generally been considered to arise from gastric
mucosa with intestinal metaplasia and undifferentiated-type
tumours to arise from ordinary gastric mucosa without intestinal
metaplasia (Lauren 1965; Nakamura et al, 1968). We previously
reported that early-stage C-Ca was more significantly associated
with G-phenotype tumours, such as tumours showing 45M1
expression and/or class III mucin as detected by paradoxical
concanavalin A staining, and more negatively associated with the
presence of intestinal metaplasia in the surrounding non-
neoplastic mucosa as compared with early-stage D-Ca (Tajima
et al, 2001a). In this study, the incidence of HGM expression was
significantly higher in C-Ca than in D-Ca among early-stage
tumours, whereas the incidence of MUC2 expression was
significantly lower in cases of C-Ca than in those of D-Ca among
the advanced-stage tumours. Therefore, differentiated-type C-Ca
may be more strongly associated with the G-phenotype than
differentiated-type D-Ca. The phenotypic marker expression
pattern has also been reported to be associated with tumour
aggressiveness in gastric carcinomas. Even differentiated-type
carcinomas of the G-phenotype are more likely to transform into
the undifferentiated-type carcinoma and show infiltrative growth
to deeper layers of the mucosa or invasion of the surrounding
structures through loss of the E-cadherin gene function than
tumours of the I-phenotype (Tajima et al, 2001b, 2004; Yamazaki
et al, 2006). Tumours exhibiting such histological transformation
have been reported to show more tumour aggressiveness in terms
of the invasiveness and propensity for metastasis than other
histologic-type tumours (Kozuki et al, 2002). Furthermore, G–
phenotype tumours have been reported to be significantly
associated with a high risk of peritoneal recurrence and a poorer
outcome after surgery as compared with tumours of other
phenotypes among patients with advanced gastric carcinoma
(Tajima et al, 2001b, 2004). Therefore, these previous data
support our findings in this study that C-Ca predominantly
showing the G-phenotype may have a greater tendency towards
histological transformation and greater tumour aggressiveness
than D-Ca.
Choi et al (2000) have reported previously that mutations of the
APC/beta-catenin pathway, unlike in colorectal carcinoma, can be
identified in only a small subset of patients with OGJ adenocarci-
noma. However, to the best of our knowledge, no previous reports
describing the association between phenotypic marker expressions
and genetic alterations, such as mutations of the APC, K-ras and
p53 genes and the MSI status between C-Ca and D-Ca have been
published so far. In this study, we confirmed that the APC gene
mutation was an extremely rare event in C-Ca, and that the
incidence of the APC gene mutation was significantly lower in
cases of C-Ca than in those of D-Ca. It has been demonstrated that
different genetic pathways according to the phenotypic marker
expression pattern of the tumour exist during gastric carcinogen-
esis (Morohara et al, 2006; Yamazaki et al, 2006). We have
previously reported that chromosomal changes, detected using a
comparative genomic hybridisation technique, differ considerably
according to the phenotypic marker expression pattern in gastric
differentiated-type carcinomas (Morohara et al, 2006). We have
also demonstrated that the APC gene mutation is a relatively
common and early event in I-phenotype tumours, but rather rare
in G-phenotype tumours, especially tumours showing HGM
expression (Yamazaki et al, 2006). Therefore, C-Ca, predominantly
showing the G-phenotype, may be associated with a lower
frequency of the APC gene mutation. Furthermore, all the findings
of the previous and the present study taken together suggest
different genetic pathways of carcinogenesis between C-Ca and
D-Ca, resulting in the differences in the phenotypic marker
expression pattern and biological behavior between the two
tumours. Recently, opposing risks of C-Ca and D-Ca associated
with Helicobacter pylori infection have been reported (Machida-
Montani et al, 2004; Kamangar et al, 2006). Therefore, the authors
think that the role of H. pylori infection in the carcinogensis may
be one of the reasons for the different genetic pathways between
C-Ca and D-Ca.
In conclusion, this study shows that C-Ca is significantly
associated with a high prevalence of LVI, oesophageal invasion and
histological transformation from differentiated- to the undiffer-
entiated-type with tumour progression, indicating that it might
be a more aggressive tumour than D-Ca. The differences in the
biological behavior between C-Ca and D-Ca may be related to both
the specific histological characteristics of the wall of the OGJ and
the different genetic pathways of carcinogenesis between the two
tumours.
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